Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **joining chain of multimeric IgA and IgM** (J chain, JCHAIN) is a small, acidic polypeptide uniquely involved in **regulating the assembly and secretion of polymeric immunoglobulins IgA and IgM** in mammals[1][2][3]. It is encoded by the IGJ gene and is incorporated into IgA and IgM molecules through disulfide bonds, allowing IgA to form dimers and IgM to form pentamers rather than hexamers[1][2][3]. The presence of the J chain is required for these polymeric immunoglobulins to bind the polymeric Ig receptor (pIgR), enabling their transcytosis across mucosal epithelia into secretions[1][2]. The J chain's function is specific to IgA and IgM, with no direct roles in other immunoglobulin classes. While it is critical for mucosal immune defense and immune complex formation, there are currently no drugs known to directly target the J chain, and there are no established safety concerns, biomarker applications, or direct therapeutic indications relevant to therapeutic targeting of this molecule[1][2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Joining chain of multimeric IgA and IgM (J chain (JCHAIN)).